FIB4 usefulness for measuring fibrosis changes following anti-HCV - Viral treatment

被引：0
|
作者：
Nalpas, Bertrand
Fontaine, Helene
Vallet-Pichard, Anais
Mallet, Vincent
Verkarre, Virginie
Pol, Stanislas
机构：
[1] Hop Cochin, Liver Unit, Paris, France
[2] Hop Cochin, INSERM, U567, F-75674 Paris, France
[3] Hop Necker Enfants Malad, Serv Anat Pathol, Paris, France
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1357
引用
收藏
页码：842A / 843A
页数：2
相关论文
共 32 条
  • [1] The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients
    Abdel-Hameed, Enass A.
    Rouster, Susan D.
    Kottilil, Shyam
    Sherman, Kenneth E.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (03) : 450 - 459
  • [2] Regression of advanced fibrosis following virological response to anti-HCV therapy
    Martinello, M.
    Chow, D. How
    Danta, M.
    Matthews, G. V.
    Dore, G. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 85 - 85
  • [3] FibroScan, APRI, FIB4, and GUCI: Role in prediction of fibrosis and response to therapy in Egyptian patients with HCV infection
    Yosry, Ayman
    Fouad, Rabab
    Alem, Shereen A.
    Elsharkawy, Aisha
    El-Sayed, Mohammad
    Asem, Noha
    Hassan, Ehsan
    Ismail, Ahmed
    Esmat, Gamal
    ARAB JOURNAL OF GASTROENTEROLOGY, 2016, 17 (02) : 78 - 83
  • [4] Direct antiviral agent (DAA) treatment of chronic HCV Infection results in rapid regression of transient elastography (Fibroscan®) and validated fibrosis markers FIB4 and APRI
    Bachofner, Jacqueline A.
    Bergamin, Irina
    Valli, Piero V.
    Kroger, Arne
    Kunzler, Patrizia
    Baserga, Adriana
    Braun, Dominique
    Fehr, Jan
    Semela, David
    Magenta, Lorenzo
    Mullhaupt, Beat
    Terzirolli, Benedetta
    Mertens, Joachim C.
    SWISS MEDICAL WEEKLY, 2016, 146 : 19S - 19S
  • [5] Natural history of chronic viral hepatitis in southern Italy: epidemiological changes since the introduction of the anti-HCV test
    Parrilli, G
    Orsini, L
    Stranges, S
    Cimino, L
    Abazia, C
    Scalice, E
    Manguso, F
    Farinaro, E
    Budillon, G
    EPIDEMIOLOGY AND INFECTION, 2003, 131 (03): : 1111 - 1115
  • [6] The dynamics of FIB4 after sustained viral response predicts the risk of liver-related complication in HCV cirrhosis (ANRS CO12 Cirvir)
    Boursier, Jerome
    Nahon, Pierre
    Guettier, Maxime
    Moreau, Clemence
    Riou, Jeremie
    Audureau, Etienne
    Roux, Marine
    JOURNAL OF HEPATOLOGY, 2020, 73 : S104 - S104
  • [7] Dynamic Changes of Hepatitis C Virus Genotype May Influence the Anti-HCV Treatment Response in HIV/HCV Infected Individuals
    Porrino, L.
    Bagaglio, S.
    Morsica, G.
    Gallotta, G.
    Hasson, H.
    Galli, L.
    Rusconi, V.
    Lazzarin, A.
    Uberti-Foppa, C.
    INFECTION, 2010, 38 : 89 - 90
  • [8] FIB 4 Score Correlates with Ultrasound Elastography Changes in HCV Patients Receiving Daas Treatment
    Shoreibah, Mohamed Galal
    Sims, Omar Tremayne
    Kommineni, Vishnu Teja
    Romano, John
    Fitzmorris, Paul S.
    Massoud, Moustafa
    Chia-Ying, Chiu
    Venkata, Krishna
    Massoud, Omar
    HEPATOLOGY, 2018, 68 : 902A - 903A
  • [9] Diagnostic Validity of FIB-4 Index for Predicting Hepatic Fibrosis in the Patients of Chronic Hepatitis C Viral (HCV) Infection
    Shaikh, Fida Hussain
    Memon, Sadik
    Daudpoto, Wali K.
    Ghori, Aamir
    Burney, Asif A.
    GASTROENTEROLOGY, 2011, 140 (05) : S979 - S979
  • [10] Regression of liver fibrosis following Sustained Viral response (SVR) with Interferon(IFN)-free HCV treatment
    Nicolini, Laura A.
    Ricci, Elena
    Menzaghi, Barbara
    Madeddu, Giordano
    Maggi, Paolo
    Di Biagio, Antonio
    Bonfanti, Paolo
    Passerini, Simone
    Magni, Carlo F.
    Salomoni, Elena
    Maurizio, Celesia Benedetto
    Patacca, Aria
    Squillace, Nicola
    Vichi, Francesca
    Falasca, Katia
    Gulminetti, Roberto
    Grosso, Carmelo
    Quirino, Tiziana
    HEPATOLOGY, 2016, 64 : 967A - 968A
1234